MetLife Announces New $3 Billion Share Repurchase Authorization

NEW YORK--(BUSINESS WIRE)-- MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $600 million remaining at the end of April 2024 under the company’s prior authorization announced in May 2023.

“This $3 billion addition to our share repurchase authorization, combined with the common stock dividend increase we announced in April, demonstrates our commitment to returning capital to shareholders, which is carefully balanced with investing in responsible growth for the future,” said MetLife President and CEO Michel Khalaf. “Our disciplined approach directs capital to the highest value opportunities and drives long-term shareholder value.”

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

Forward-Looking Statements

The forward-looking statements in this news release, using words such as “commitment,” “growth,” and “long-term,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501244741/en/

For Media:

Dave Franecki

973-264-7465

Dave.Franecki@metlife.com

For Investors:

John Hall

212-578-7888

John.A.Hall@metlife.com

Source: MetLife, Inc.